U.S. Transportation Stock News

TJX Companies (TJX) has set the tone for Q1 2027 earnings season with recent quarterly revenue of about US$17.7 billion, basic EPS of US$1.58 and net income of roughly US$1.8 billion anchoring the latest report. The company has seen revenue move from US$14.1 billion in Q3 2026 to US$17.7 billion in Q4 2026, while basic EPS over that stretch ranged from US$1.30 to US$1.58. This gives a clear view of how the top and bottom lines have been tracking into this quarter. Taken together with a higher...

Context for Dolby Laboratories after recent share performance Dolby Laboratories (DLB) has drawn investor attention after the stock fell about 16% over the past month and roughly 16% over the past 3 months, against annual revenue of US$1.36b and net income of US$243.65m. See our latest analysis for Dolby Laboratories. At a share price of US$54.12, Dolby’s momentum has softened, with the stock down about 16% on a 1 month share price basis and its 1 year total shareholder return lower at around...

Event overview and recent performance snapshot Genco Shipping & Trading (GNK) is back on investors’ radar after a recent 1 day gain of 1.7%, in contrast to a decline of 5.4% over the past week and a modest slip over the past month. See our latest analysis for Genco Shipping & Trading. That short term setback over the past week sits alongside a 30.7% year to date share price return and an 87.9% total shareholder return over one year, suggesting momentum has cooled recently after a strong...

Denali Therapeutics recently reported a first-quarter 2026 net loss of US$128.45 million, slightly improving year on year, while also sharing updates on its initial commercial rollout of AVLAYAH for Hunter syndrome and presenting at industry and investor conferences earlier in May. The early, stronger-than-expected uptake of AVLAYAH is drawing attention to Denali’s brain-penetrant drug platform and its broader rare disease pipeline. We’ll now look at how robust early AVLAYAH demand may...

Culper Research’s short report accusing ADMA Biologics (ADMA) of inflating revenue by encouraging a distributor to hold excess stock has triggered securities fraud investigations and multiple class action efforts, putting the company’s reported growth and guidance under scrutiny. See our latest analysis for ADMA Biologics. At a share price of US$8.56, ADMA’s recent legal headlines have coincided with sharp share price pressure, including a 30 day share price return down 21.32% and a 90 day...

TMC the metals (TMC) has drawn fresh investor focus after signing a detailed development and commercial production agreement with Allseas to build and operate what the company expects will be the first commercial nodule collection system. See our latest analysis for TMC the metals. The Allseas agreement and recent Q1 update come against a mixed price backdrop, with the 1 day share price return of 1.8% contrasting with share price returns that are down around 10% over the past month and...

Hims & Hers Health (NYSE:HIMS) has launched generic semaglutide for weight loss in Canada as part of its international expansion. This marks the company’s first introduction of a generic GLP-1 medication outside the U.S. The new offering targets obesity and metabolic health treatments for Canadian patients. Hims & Hers Health focuses on direct to consumer telehealth, using an AI driven platform to connect patients with personalized treatments across categories like mental health, sexual...

MannKind Corporation recently reported Q1 2026 revenues of US$90.2 million, a 15% year-on-year increase driven mainly by Furoscix net sales and Tyvaso DPI royalties, alongside an expanded collaboration with United Therapeutics that includes a US$5 million payment to accelerate Ralinepag DPI development. With key upcoming FDA action dates for Afrezza’s pediatric indication and the Furoscix ReadyFlow Autoinjector, MannKind’s revenue mix and partnership profile are becoming more closely tied to...

Watts Water Technologies (WTS) is back in focus after recent analyst upgrades and a Q1 earnings beat highlighted solid organic sales growth, stronger data center demand, and better free cash flow margins. See our latest analysis for Watts Water Technologies. Despite the recent Q1 beat and M&A commentary, short term momentum has been mixed, with a 1 day share price return of 1.04% but a 90 day share price return down 9.16%, while the 1 year total shareholder return of 26.62% and 5 year total...

Gaming and Leisure Properties, Inc. previously announced that its Board approved a second-quarter 2026 cash dividend of US$0.82 per share, a 5% increase from the prior payout, payable on June 26, 2026 to shareholders of record on June 12, 2026. This higher dividend underscores the REIT’s emphasis on consistent cash distributions backed by recurring triple-net lease income from its gaming real estate portfolio. With this 5% dividend increase now in place, we’ll examine how a richer cash...

In recent announcements, American Water Works’ subsidiaries outlined extensive 2026 infrastructure programs, including roughly US$277,000,000 in California, US$290,000,000 in Illinois, over US$40,000,000 in Tennessee, and about US$17,800,000 for Pennsylvania storage tanks, alongside completing a US$4,000,000 main replacement in Bellflower, California. Together with a new US$500,000,000 senior notes issue, these projects highlight the company’s heavy capital commitment to modernizing...

Array Technologies recently reported a surprise Q1 2026 profit with adjusted EPS of US$0.06, beat revenue expectations, and ended the quarter with a record US$2.40 billion order book while forecasting strong revenue and EBITDA growth for the rest of the year. A new role as tracker supplier for Statkraft’s high‑altitude Lupi solar project in Peru underscores Array’s growing international footprint and ability to deploy its technology in demanding environments. With that backdrop of a surprise...

In May 2026, Acuity Inc. entered into a new unsecured revolving credit agreement led by JPMorgan Chase, replacing its 2022 facility and providing up to $800 million of availability maturing in May 2031, subject to leverage-based covenants and customary restrictions. This long-dated, flexible borrowing capacity, tied to Acuity’s leverage ratio or credit rating, gives the company additional financial room to support operations, acquisitions, and ongoing capital allocation choices. Next, we’ll...

In the past quarter, Nu Holdings Ltd. reported record first‑quarter 2026 results, with net income rising to US$872.06 million and basic earnings per share from continuing operations increasing to US$0.1796, alongside strong customer growth past 135 million and robust revenue expansion across Latin America. Despite this operational strength, the company’s slight earnings-per-share miss versus consensus and higher credit provisions in a tougher Latin American backdrop have raised fresh...

Pentair recently drew renewed attention after hitting a yearly trading low, even as it continues to report resilient operational performance in water treatment, filtration, and fluid management across residential, commercial, and industrial markets. This combination of operational resilience, cautious management commentary, and growing interest in long-cycle water infrastructure has sharpened investor focus on Pentair’s fundamentals and long-term role in global water systems. With investor...

In early May 2026, GATX Corporation reported first-quarter 2026 results showing higher year-over-year sales of US$518.7 million and revenue of US$583.7 million, alongside net income of US$85.5 million and diluted earnings per share from continuing operations of US$2.35, while reiterating full-year 2026 earnings guidance of US$9.50 to US$10.10 per diluted share. A few days later, GATX filed a US$237.93 million shelf registration for 1,300,000 common shares tied to an ESOP-related offering,...

What Ecolab’s new bond offerings mean for equity investors Ecolab (ECL) has just tapped the bond market with several fixed rate note offerings totaling multiple billions of US dollars, across maturities from 2029 to 2036, drawing fresh attention to the stock. The company issued callable, senior unsecured notes with fixed coupons, including 4.600% notes due 2029, 4.800% notes due 2031, 5.150% notes due 2033, and 5.350% notes due 2036, each priced slightly below par. See our latest analysis for...

Preferred Bank recently announced it had reached a settlement to recover US$5.7 million over eleven months on a commercial and industrial loan that was previously charged off in the second quarter of 2024, and reported first-quarter 2026 earnings per share of US$2.53 with revenue coming in below forecasts. This combination of an unexpected cash recovery on a written-off loan and an earnings beat on per-share profit adds a fresh dimension to how investors may assess the bank's credit...

Syndax Pharmaceuticals (SNDX) is back in focus after highlighting 12 new Revuforj abstracts ahead of the European Hematology Association 2026 Congress, drawing attention to extensive clinical and real-world data across acute leukemia settings. See our latest analysis for Syndax Pharmaceuticals. The recent Revuforj data spotlight comes as Syndax’s share price sits at US$20.13, with a year to date share price return down 5.49% but a 1 year total shareholder return of 89.01%, suggesting longer...

In early May 2026, Privia Health Group reported first-quarter results showing sales rising to US$603.85 million from US$480.10 million a year earlier, while net income eased to US$3.06 million from US$4.22 million and diluted EPS held at US$0.02. At the same time, the company maintained its 2026 GAAP revenue outlook of US$2.35 billion to US$2.45 billion, indicating confidence in meeting full-year expectations despite slimmer quarterly profits. We’ll now examine how sustaining full-year...

Core & Main (CNM) has been drawing fresh attention as it reports wider free cash flow margins, continues share repurchases, and steps up visibility at water industry conferences in Kentucky, North Carolina, and New Jersey this May. See our latest analysis for Core & Main. At a share price of US$47.12, Core & Main has seen a 1-day share price return of 4.73%, although the share price is down 11.78% year to date and the 1-year total shareholder return is down 10.57%. The 3-year total...

Packaging Corporation of America (PKG) is back on investors’ radar after its recent share price move, with the stock now around $213.21 and showing mixed returns across the past week, month, and past 3 months. See our latest analysis for Packaging Corporation of America. The recent 1-day share price gain of 4.94% contrasts with a 90 day share price return that is down 10.77%, while the 1 year total shareholder return of 14.50% points to momentum that has been building over a longer...

Event driven focus on CRISPR Therapeutics stock CRISPR Therapeutics (CRSP) is back on investor radars after recent positive revisions to earnings projections and fresh updates on the commercial rollout of CASGEVY, including reimbursement progress in Germany and ongoing patient initiations. See our latest analysis for CRISPR Therapeutics. Despite the recent news flow, CRISPR Therapeutics’ share price is US$48.55 after a 1-day share price return of 2.02%. However, the 30-day share price return...

In the past few days, Tsakos Energy Navigation reported fourth-quarter 2025 results that materially exceeded earnings and revenue expectations, underscoring strong operational performance in its energy transportation business. This outperformance against analyst forecasts highlights the company’s ability to leverage its fleet and contracts more efficiently than the market had anticipated. We’ll now examine how this earnings beat, and what it suggests about Tsakos Energy Navigation’s...